However, since CD80 is predominantly expressed by professional APCs and rarely by tumor cells, the interplay between the PD-1/PD-L1 and CD28/CTLA-4/CD80 pathways is likely to be more relevant in the context of T cell-APC interactions. Here, CD80 is linked to neoplasm.